← All stocks

Evolus, Inc.

EOLS Net selling
CIK 0001570562 #3025 in the set updated 17 Sep 2026
Bought (120 mo)
$53.94M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$287.88M
$3.91M on a plan · $4.22M straight out of an exercise
Sold at will
$279.75M
69 of 97 sales
Net
−$233.94M
−$225.81M against sales at will

By person

21 insiders · 142 transactions
5.8×

David Moatazedi holds 5.8 times base salary in stock. $4.52M of shares against $775.00K in salary for 2025.

Salary from the company's own proxy. The shares are what David Moatazedi last reported holding, valued at $9.04, the price Common Stock was last bought or sold at on the open market here, on 2 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
AEON Biopharma, Inc. entity
Former 10% Owner
$190.83M (7)
−$190.83M
0
$0.00
−100.0%
Alphaeon 1 LLC entity
10% owner
$40.22M (2)
−$40.22M
10,279,742
$92.91M
−30.2%
Medytox Inc. entity
Former 10% Owner
$8.06M (15)
$33.81M (10)
−$25.75M
10,640,826
$96.18M
−24.1%
Malik Vikram
Director
$26.65M (4)
$2.09M (7)
+$24.56M
1,464,810
$13.24M
+6,659%
MOATAZEDI DAVID
See Remarks
$16.48M (29)
−$16.48M
499,592
$4.52M
BLANK SIMONE
Director
$16.41M (3)
+$16.41M
927,471
$8.38M
Avelar Rui
See Remarks
$1.91M (15)
−$1.91M
427,423
$3.86M
+326.5%
Romine Kristine
Director
$1.54M (11)
+$1.54M
84,359
$762.48K
SILVERNAIL LAUREN P
See Remarks
$1.19M (6)
−$1.19M
141,571
$1.28M
Beaver Sandra
Chief Financial Officer
$437.75K (9) scheduled
−$437.75K
167,089
$1.51M
Parschauer Karah Herdman
Director
$324.20K (2)
−$324.20K
77,742
$702.67K
Hau Bosun
Director
$309.73K (2)
+$309.73K
10,040
$90.75K
Jafar Michael M.
See Remarks
$266.59K (1)
$20.13K (1)
+$246.46K
219,851
$1.99M
+109,826%
Stewart Brady
Director
$204.49K (1)
+$204.49K
134,188
$1.21M
GILL DAVID N
Director
$65.60K (2)
$268.67K (4)
−$203.07K
86,887
$785.33K
Yamagishi-Dressler Tomoko
Chief Marketing Officer
$192.35K (3) scheduled
−$192.35K
89,949
$813.00K
White Albert G III
Director
$189.00K (1)
+$189.00K
95,937
$867.13K
HAYMAN ROBERT
Director
$153.86K (3)
+$153.86K
65,222
$589.51K
+197,542%
Muilenburg Crystal
Chief Marketing Officer
$123.11K (2)
−$123.11K
134,248
$1.21M
+57.2%
FARRELL PETER C
Director
$91.05K (1)
+$91.05K
53,174
$480.61K
Mitchell Tatjana
Chief Financial Officer
226,092
$2.04M

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Insider
Date
Role
Action
Shares
Price
Amount
MOATAZEDI DAVID
2 Sep 2026
See Remarks
Sell
105,108
$9.04
$950.02K
Avelar Rui
20 Mar 2026
See Remarks
Sell
3,119
$4.75
$14.82K
MOATAZEDI DAVID
16 Jun 2025
See Remarks
Sell
16,582
$9.89
$164.05K
MOATAZEDI DAVID
13 Jun 2025
See Remarks
Sell
111,323
$10.05
$1.12M
Parschauer Karah Herdman
12 Mar 2025
Director
Sell
12,888
$12.99
$167.47K
Beaver Sandra
6 Sep 2024
Chief Financial Officer
Sell
3,276
$14.98
$49.07K
Yamagishi-Dressler Tomoko
30 Aug 2024
Chief Marketing Officer
Sell
5,631
$15.85
$89.25K
MOATAZEDI DAVID
4 Jun 2024
See Remarks
Sell
140,214
$12.73
$1.78M
Malik Vikram
3 Jun 2024
Director
Sell
7,500
$12.96
$97.20K
GILL DAVID N
14 May 2024
Director
Sell
6,718
$12.60
$84.65K
Malik Vikram
13 May 2024
Director
Sell
28,000
$12.93
$362.01K
GILL DAVID N
13 May 2024
Director
Sell
3,643
$12.72
$46.36K
Beaver Sandra
10 May 2024
Chief Financial Officer
Sell
2,423
$12.72
$30.81K
Avelar Rui
10 May 2024
See Remarks
Sell
3,441
$12.72
$43.76K
MOATAZEDI DAVID
10 May 2024
See Remarks
Sell
16,051
$12.72
$204.13K
MOATAZEDI DAVID
27 Mar 2024
See Remarks
Sell
6,236
$13.86
$86.43K
MOATAZEDI DAVID
19 Mar 2024
See Remarks
Sell
96,566
$13.92
$1.34M
Beaver Sandra
19 Mar 2024
Chief Financial Officer
Sell
5,672
$13.92
$78.98K
Avelar Rui
19 Mar 2024
See Remarks
Sell
27,603
$13.92
$384.35K
MOATAZEDI DAVID
8 Dec 2023
See Remarks
Sell
31,300
$9.73
$304.51K
MOATAZEDI DAVID
6 Dec 2023
See Remarks
Sell
51,348
$10.09
$517.89K
Medytox Inc.
16 Oct 2023
Former 10% Owner
Sell
1,690,663
$7.50
$12.68M
Avelar Rui
14 Mar 2023
See Remarks
Sell
14,906
$8.47
$126.24K
MOATAZEDI DAVID
14 Mar 2023
See Remarks
Sell
64,211
$8.47
$543.80K
Alphaeon 1 LLC
17 Feb 2023
10% owner
Sell
1,850,000
$8.40
$15.54M
Medytox Inc.
7 Feb 2023
10% owner
Sell
2,187,511
$8.50
$18.59M
Medytox Inc.
20 Jan 2023
10% owner
Sell indirect
37,043
$11.04
$408.95K
Medytox Inc.
6 Oct 2022
10% owner
Sell
38,304
$8.99
$344.42K
Medytox Inc.
5 Oct 2022
10% owner
Sell
6,848
$8.95
$61.29K
Medytox Inc.
15 Sep 2022
10% owner
Sell
24,000
$10.34
$248.10K
Medytox Inc.
14 Sep 2022
10% owner
Sell
73,000
$10.27
$749.67K
Medytox Inc.
9 Sep 2022
10% owner
Sell
20,700
$10.53
$217.91K
Medytox Inc.
8 Sep 2022
10% owner
Sell
15,300
$10.39
$158.98K
Medytox Inc.
1 Aug 2022
10% owner
Sell
26,000
$13.28
$345.36K
SILVERNAIL LAUREN P
18 May 2022
See Remarks
Sell
52,015
$12.42
$646.03K
SILVERNAIL LAUREN P
17 May 2022
See Remarks
Sell
16,189
$13.92
$225.35K
GILL DAVID N
16 May 2022
Director
Sell
5,000
$13.62
$68.08K
MOATAZEDI DAVID
16 May 2022
See Remarks
Sell
55,321
$13.64
$754.31K
GILL DAVID N
13 May 2022
Director
Sell
5,313
$13.10
$69.58K
MOATAZEDI DAVID
28 Mar 2022
See Remarks
Sell
6,104
$11.62
$70.93K
SILVERNAIL LAUREN P
8 Mar 2022
See Remarks
Sell
10,192
$9.73
$99.12K
Avelar Rui
8 Mar 2022
See Remarks
Sell
10,192
$9.73
$99.12K
MOATAZEDI DAVID
8 Mar 2022
See Remarks
Sell
37,972
$9.73
$369.29K
Muilenburg Crystal
8 Mar 2022
Chief Marketing Officer
Sell
6,495
$9.73
$63.17K
Alphaeon 1 LLC
2 Sep 2021
10% owner
Sell
2,597,475
$9.50
$24.68M
Malik Vikram
23 Aug 2021
Director
Sell indirect
26,077
$11.00
$286.72K
Malik Vikram
20 Aug 2021
Director
Sell indirect
49,878
$10.61
$529.32K
Malik Vikram
19 Aug 2021
Director
Sell indirect
11,962
$10.50
$125.56K
Malik Vikram
18 Aug 2021
Director
Sell indirect
25,000
$10.44
$261.01K
Malik Vikram
17 Aug 2021
Director
Sell indirect
42,083
$10.06
$423.55K
MOATAZEDI DAVID
16 Aug 2021
See Remarks
Sell
47,737
$11.35
$541.74K
MOATAZEDI DAVID
13 Aug 2021
See Remarks
Sell
22,708
$10.66
$242.07K
MOATAZEDI DAVID
10 Aug 2021
See Remarks
Sell
41,763
$11.18
$466.84K
Muilenburg Crystal
10 Aug 2021
Chief Marketing Officer
Sell
5,362
$11.18
$59.94K
Avelar Rui
10 Aug 2021
See Remarks
Sell
14,293
$11.18
$159.79K
SILVERNAIL LAUREN P
10 Aug 2021
See Remarks
Sell
14,293
$11.18
$159.77K
MOATAZEDI DAVID
25 Jan 2021
See Remarks
Sell
8,310
$7.46
$61.99K
Avelar Rui
25 Jan 2021
See Remarks
Sell
2,699
$7.46
$20.13K
Jafar Michael M.
25 Jan 2021
See Remarks
Sell
2,699
$7.46
$20.13K
SILVERNAIL LAUREN P
25 Jan 2021
See Remarks
Sell
2,699
$7.46
$20.13K
Avelar Rui
7 Jan 2020
See Remarks
Sell
39,442
$10.71
$422.28K
AEON Biopharma, Inc.
3 Jun 2019
10% owner
Sell
1,298,701
$19.25
$25.00M
SILVERNAIL LAUREN P
31 May 2019
See Remarks
Sell
2,612
$13.53
$35.35K
AEON Biopharma, Inc.
22 May 2019
10% owner
Sell
290,518
$19.25
$5.59M
AEON Biopharma, Inc.
20 May 2019
10% owner
Sell
1,017,422
$19.25
$19.59M
AEON Biopharma, Inc.
20 May 2019
10% owner
Sell
4,000,000
$19.25
$77.00M
AEON Biopharma, Inc.
29 Nov 2018
10% owner
Sell
573,888
$14.00
$8.03M
AEON Biopharma, Inc.
11 Sep 2018
10% owner
Sell
1,750,000
$21.04
$36.82M
AEON Biopharma, Inc.
23 Jul 2018
10% owner
Sell
1,000,000
$18.80
$18.80M

What was left out

Form 4 filings counted 224
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 26
Sales straight out of an exercise 2
Sales at will 69
Transactions with no price 0
Shares from compensation/vesting 15,064,534
Sales filed before the plan box existed 47
History held since 13 Feb 2018